Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
434.30    -0.90 (-0.21%)
Bid:
436.00
Ask:
436.10
Spread: 0.10 (0.023%)
Market Cap: £10.93b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Directorate Change

4 Mar 2021 07:05

RNS Number : 1024R
Rentokil Initial PLC
04 March 2021
Β 

4 March 2021

Β 

Β 

Directorate Changes including Appointment of Non-Executive Director

Β 

Rentokil Initial plc (FTSE: RTO, "the Company") today announces the appointment of Sarosh Mistry to its Board as a Non-Executive Director with effect from 1 April 2021. Sarosh will also become a member of the Remuneration Committee and the Nomination Committee from this date.

Β 

Sarosh has extensive experience as a senior executive, driving organic and inorganic growth in business-to-business services, especially in North America. He has deep experience of building businesses across the healthcare, retail, facilities management, hospitality, financial services and consumer technology industries, including innovation-led growth, service line extensions and new country entries (including emerging markets in Latin America and Asia). His executive experience has been in complex, geographically dispersed and multi-site businesses operating globally.

Β 

Sarosh is Chairman of Sodexo's North American services, which include clinical technology in health care settings, SaaS-based digital ecosystems, and food-focused delivery. He is also CEO of Sodexo's global Home Care Services business and a member of the listed group's executive committee. Prior to joining Sodexo in 2011, he worked in senior roles in major business-to-business and consumer organisations Compass, Starbucks, Aramark and Pepsico. Sarosh has a Bachelor's degree from St John's University, and a MBA from the A. Gary Anderson Graduate School of Management.

Β 

Commenting on the appointment Richard Solomons, Chairman, said:

Β 

"We are delighted to welcome Sarosh to the Board of Rentokil Initial. He has a track record of leading transformative growth and success in major support services businesses in our largest market, North America, as well as globally. We are confident that his experience and personal qualities will enable him to make a strong contribution to the Board."Β 

Β 

There are no further details to be disclosed relating to Sarosh Mistry under Section 9.6.13 of the Listing Rules.

Β 

Other Board Changes

Β 

Angela Seymour-Jackson, Non-Executive Director and Chair of the Remuneration Committee, has informed the Company that, having served on the Board for a period of 9 years, she does not intend to stand for re-election at the Company's AGM on 12 May 2021 and will, therefore, retire as a director of the Company from the conclusion of the meeting. The Company is pleased to announce that Cathy Turner, a Non-Executive Director and member of the Remuneration Committee since April 2020, will succeed Angela as Chair of the Remuneration Committee.

Β 

Commenting on the changes to Board, Richard Solomons, Chairman of Rentokil Initial, said: "I would like to thank Angela for her very significant contribution to the Board since she joined it in 2012, and for her work on the Remuneration Committee including as Chair since 2019. I'd also like to congratulate Cathy on her new appointment."

Β 

Β 

For further information please contact:

Β 

Rentokil Initial plc

Β 

Media

Malcolm Padley

07788 978199

Company Secretary

Daragh Fagan

07990 561702

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOAUPUCUWUPGPGW
Date   Source Headline
31st Mar 20211:16 pmRNSTotal Voting Rights
31st Mar 202110:33 amRNSAnnual Financial Report
30th Mar 20216:23 pmRNSDirector Declaration
24th Mar 20215:55 pmRNSDirector/PDMR Shareholding
12th Mar 20219:00 amRNSAdditional Listing
4th Mar 20217:05 amRNSDirectorate Change
4th Mar 20217:00 amRNSFinal Results
17th Feb 20215:45 pmRNSDirector Declaration
8th Jan 20217:00 amRNSQ4 2020 Acquisitions and Trading Update
27th Nov 20202:25 pmBUSEarly Repurchase(s)
27th Nov 20202:22 pmBUSEarly Repurchase(s)
24th Nov 20205:25 pmRNSDirector/PDMR Shareholding
20th Nov 20207:00 amRNSResult of Tender Offer for Notes due 2021
12th Nov 20209:02 amRNSTender Offer for Notes due 2021
22nd Oct 20207:00 amRNSQ3 Trading Update
8th Oct 20207:00 amRNSSuccessful EUR600m 8-year bond transaction priced
1st Oct 20209:00 amRNSBlock listing Interim Review
28th Aug 20203:40 pmRNSDirector/PDMR Shareholding
7th Aug 20205:24 pmRNSDirector/PDMR Shareholding
30th Jul 20207:00 amRNSInterim Results
6th Jul 20207:00 amRNSDirectorate Change
21st May 202011:00 amRNSDirector/PDMR Shareholding
13th May 20205:15 pmRNSResult of AGM
7th May 20204:45 pmRNSDirector/PDMR Shareholding
27th Apr 20203:50 pmRNSDisclosure of Rights Attached to Equity Shares
17th Apr 202011:59 amRNSDirector/PDMR Shareholding
16th Apr 20207:00 amRNSQ1 Trading Update
14th Apr 20205:26 pmRNSHolding(s) in Company
9th Apr 20204:35 pmRNSDirector/PDMR Shareholding
2nd Apr 20201:36 pmRNSDirector/PDMR Shareholding
1st Apr 20205:33 pmRNSConfirmation of Non-Executive Director Appointment
1st Apr 20209:24 amRNSBlock listing Interim Review
31st Mar 20202:18 pmRNSTotal Voting Rights
30th Mar 202012:37 pmRNSRedemption of 4.5% debenture stock
30th Mar 202012:24 pmRNSRedemption of 5% debenture stock
27th Mar 202011:00 amRNSHolding(s) in Company
26th Mar 20204:41 pmRNSSecond Price Monitoring Extn
26th Mar 20204:36 pmRNSPrice Monitoring Extension
26th Mar 202011:29 amRNSAnnual Financial Report
25th Mar 20207:00 amRNSTrading Update
19th Mar 202011:30 amRNSDirector Declaration
17th Mar 20201:15 pmRNSAdditional Listing
6th Mar 202012:00 pmRNSHolding(s) in Company
27th Feb 20207:05 amRNSDirectorate Change
27th Feb 20207:00 amRNSFinal Results
21st Feb 20204:00 pmRNSHolding(s) in Company
24th Dec 20191:10 pmRNSHolding(s) in Company
19th Dec 20192:40 pmRNSDirector/PDMR Shareholding
17th Dec 20195:10 pmRNSHolding(s) in Company
26th Nov 20196:03 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.